论文部分内容阅读
作者采用血清溶胶原-Ⅲ-前肽(P-Ⅲ-P)(serumpropeptide-Ⅲ-propeptide)、胆基甘氨酸(Colyglycine)及新喋呤(neopterin)三种血清生化指标测定,作为评价吡喹酮治疗肝脾型曼氏血吸虫病对疾病活动性、门脉阻塞和/或侧枝形成的效果。23例患者和25例非感染者均来自巴西东北部的曼氏血吸虫病流行区。按门脉高压并发症的有无将患者分成代偿组和失代偿组。治疗前临
The authors used three serum biochemical markers seropropeptide-Ⅲ-P (serumpropeptide-Ⅲ-propeptide), cholecyglycine (Colyglycine) and neopterin (neopterin) as a measure of praziquantel Treatment of schistosomiasis liver and spleen type Schistosomiasis disease activity, portal vein obstruction and / or collateral formation. Twenty-three patients and 25 non-infected patients were from the endemic area of Schistosoma mansoni in northeastern Brazil. According to whether the complications of portal hypertension patients will be divided into compensatory group and decompensated group. Pro before treatment